ScoutQuest30 Oct 2026
Dhanuka Agritech507717Quarterly results

Dhanuka Agritech Q2 FY2026-27: revenue up 9.91% to Rs. 657.51 crore, PAT up 16.23%; guides lower single digit FY27 growth

Q2 FY27 revenue up 9.91% to Rs. 657.51 Cr, EBITDA up 11.88% to Rs. 152.97 Cr, PAT up 16.23% to Rs. 109.22 Cr.

By ScoutQuest · · 1 min read

Rs. 657.51 Crores+9.9%
Q2 FY26Rs. 598.25 CroresQ2 FY27Rs. 657.51 Crores
Revenue from operations: Rs. 598.25 Crores (Q2 FY26) and Rs. 657.51 Crores (Q2 FY27).
Q2 FY27 revenue
up 9.91% to Rs. 657.51 Cr
Q2 FY27 PAT
up 16.23% to Rs. 109.22 Cr
FY27 guidance
revenue to lower single digit growth with EBITDA margin decline of approx. 125bps
Period
Q2 FY2026-27
Positioning
Dhanuka describes itself as a leading Indian agrochemical company with Pan-India reach to over 10 million farmers through 41 warehouses, 6,500+ distributors and 80,000+ retailers.

📉 Q2 FY2026-27 revenue from operations was Rs. 657.51 Crores against Rs. 598.25 Crores a year earlier (9.91%), EBITDA Rs. 152.97 Crores (margin 23.27%) and PAT Rs. 109.22 Crores (margin 16.61%), even as gross margin slipped to 41.18% from 42.45%. Full-year FY26 revenue was 2019.79 crore, down 0.75%.

🔬 The chairman says the sector faced a weak quarter with monsoon rainfall 13% lower and high raw material costs; herbicides were hit (8% of Q2 revenue vs 9%) while insecticides grew to 47%. New molecules were 12.84% of H1 FY27 revenue versus 16.14% in H1 FY26.

📉 Management guides FY 2026-27 revenue to lower single digit growth and expects EBITDA to decline approx. 125bps. The company says the Dahej plant will hit 70.75% utilisation by year end, prompting capacity expansion there, and will begin manufacturing products acquired from Bayer AG.

🔬 The presentation lists a pipeline focused on margin accretive 9(3) products, with a target to launch several new products over the next two years, and positions the Bayer fungicide acquisition as a step to becoming a global player.

12.84%Molecules share of revenue
Molecules share of revenue: 12.84%.
More numbers
  • Revenue from operations, Q2 FY27Rs. 657.51 Crores
  • Revenue from operations, Q2 FY26Rs. 598.25 Crores
  • EBITDA, Q2 FY27Rs. 152.97 Crores
  • PAT, Q2 FY27Rs. 109.22 Crores
  • Revenue growth YoY, Q2 FY279.91%
  • PAT growth YoY, Q2 FY2716.23%
  • EBITDA margin, Q2 FY2723.27%
  • Gross profit margin, Q2 FY2741.18%
  • Revenue from operations, FY262019.79 (Rs.in Crores)
  • PAT, FY26287.23 (Rs.in Crores)
  • Basic EPS, Q2 FY2724.43
  • New molecules share of revenue, H1 FY2712.84%
  • Dahej plant capacity utilisation expected by FY end70.75%
Source: BSE · 30 Oct 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev